Xylem Clinical Research Private Limited

Xylem Clinical Research Private Limited - research & development in Delhi, India. Directors, charges & compliance details.
CIN U73100DL2008PTC185551 Incorporated 05 December 2008 ROC Delhi HQ Delhi, India
Struck Off Private Limited Company research and development
Revenue · FY 2021
₹1,590
Latest filing
Authorised capital
₹5 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
18 yrs
Est. 2008
Directors on board
2
As per MCA filings
GST registrations
1
None active
Last financials
Mar 2023
Balance sheet date
Last AGM
30 Sep 2023
Annual general meeting

About Xylem Clinical Research Private Limited

Data last updated:

Xylem Clinical Research Private Limited was a private limited company based in Delhi, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the research and development sector. It was incorporated on 05 December 2008.

The company was registered with the Registrar of Companies (ROC), Delhi, under CIN U73100DL2008PTC185551. The company has 1 GST registration on record, which is no longer active.

The company had an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Sanjay Gupta and Shriram Arvind Inamdar.

Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office was at D – 21 Tandon Road Adarsh Nagar, Delhi, India – 110033.

The last known website on record is catalystclinicalservices.com.

Company details

CIN U73100DL2008PTC185551
Registration Number 185551
Incorporation Date 05 December 2008
ROC Delhi
Listing Status Unlisted
Company Status Struck Off
Compliance Status Active Compliant

Contact details

Xylem Clinical Research Private Limited's registered office is in Delhi, Delhi. Its website is catalystclinicalservices.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Social Media
  • Registered Address
    D – 21 Tandon Road Adarsh Nagar, Delhi, India – 110033
  • Industry
    Research & Development, Research & Development

To see the full contact details of Xylem Clinical Research Private Limited, buy the company report.

Comprehensive company report
Xylem Clinical Research Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Xylem Clinical Research Private Limited

FY 2023 filings available

Xylem Clinical Research Private Limited reported revenue of ₹1,590 for FY 2021.

Revenue · FY 2021
₹1,590

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
3 years · compounded
▼ 87%
5 years · compounded
▼ 72%

Revenue has declined at a compounded annual rate (CAGR) of 72% over five years. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2020-21FY 2019-20FY 2018-19FY 2017-18FY 2016-17
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA
Profit Before Tax
Tax Expense
Net Profit (PAT)
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2020-21FY 2019-20FY 2018-19FY 2017-18FY 2016-17
Profitability
EBITDA Margin
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Xylem Clinical Research Private Limited, buy the company report.

Board of directors of Xylem Clinical Research Private Limited

Xylem Clinical Research has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.

Directors (as last reported)
NameDesignationAppointment DateTenureStatus
Sanjay GuptaDirector06 Jan 201214 Years 10 MonthsAs last reported
Shriram Arvind InamdarDirector06 Jan 201214 Years 10 MonthsAs last reported

Shareholding

The shareholding of Xylem Clinical Research Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2017FY 2016
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Xylem Clinical Research Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Xylem Clinical Research Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Xylem Clinical Research has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.

Total GSTINs
1
Cancelled / inactive
1

To see the full GST registrations and return filing status of Xylem Clinical Research Private Limited, buy the company report.

Recent activity

Xylem Clinical Research Private Limited has 4 board changes on record since 2012: 2 appointments and 2 cessations. The latest: Aruna Gupta ceased to be Director on 30 Jan 2012.

AGM
Xylem Clinical Research Private Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.
Filing
Xylem Clinical Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi.
Ceased
Aruna Gupta ceased to be Director.
Ceased
Shruti Shreeram Inamdar ceased to be Director.
Appointed
Sanjay Gupta was appointed as Director.
Appointed
Shriram Arvind Inamdar was appointed as Director.
Incorporation
05 Dec 2008
Xylem Clinical Research Private Limited was registered on 05 Dec 2008 with Roc Delhi & aged 17 years 11 months as per MCA records.

Frequently asked questions

Xylem Clinical Research has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.

Xylem Clinical Research was a private limited company based in Delhi, India. The company worked in the research and development industry. It was incorporated on 05 December 2008 and is registered under CIN U73100DL2008PTC185551. The company has been struck off by the Registrar of Companies and is no longer operational.

Xylem Clinical Research had 2 directors:

The CIN (Corporate Identification Number) of Xylem Clinical Research is U73100DL2008PTC185551. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

The registered office of Xylem Clinical Research is at D – 21 Tandon Road Adarsh Nagar, Delhi, India – 110033.

Xylem Clinical Research was incorporated on 05 December 2008. It is registered with the Registrar of Companies, Delhi.

Xylem Clinical Research can be reached through the website catalystclinicalservices.com. Its registered office is in Delhi, India.

The latest financial statements of Xylem Clinical Research on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from 2015 are in the company report.

No. Xylem Clinical Research has 1 GST registration on record and it is cancelled or inactive.

Xylem Clinical Research operated in the research and development industry. It worked in this industry before it was struck off.